PRAVASTATIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Pravastatin Sodium patents expire, and what generic alternatives are available?
Pravastatin Sodium is a drug marketed by Accord Hlthcare, Apnar Pharma Lp, Apotex, Aurobindo Pharma, Biocon Pharma, Chartwell Rx, Cipla, Dr Reddys Labs Inc, Glenmark Pharms Ltd, Hisun Pharm Hangzhou, Norvium Bioscience, Pliva Hrvatska Doo, Ranbaxy Labs Ltd, Teva, Teva Pharms, Watson Labs, and Zydus Pharms Usa. and is included in eighteen NDAs.
The generic ingredient in PRAVASTATIN SODIUM is pravastatin sodium. There are sixteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pravastatin Sodium
A generic version of PRAVASTATIN SODIUM was approved as pravastatin sodium by TEVA on April 24th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRAVASTATIN SODIUM?
- What are the global sales for PRAVASTATIN SODIUM?
- What is Average Wholesale Price for PRAVASTATIN SODIUM?
Summary for PRAVASTATIN SODIUM
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 18 |
| Finished Product Suppliers / Packagers: | 41 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Clinical Trials: | 30 |
| Patent Applications: | 6,634 |
| Drug Prices: | Drug price information for PRAVASTATIN SODIUM |
| Drug Sales Revenues: | Drug sales revenues for PRAVASTATIN SODIUM |
| DailyMed Link: | PRAVASTATIN SODIUM at DailyMed |
See drug prices for PRAVASTATIN SODIUM
Recent Clinical Trials for PRAVASTATIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Maryland, Baltimore | Phase 4 |
| University of Thessaly | N/A |
| University of Southern California | Phase 2 |
Pharmacology for PRAVASTATIN SODIUM
| Drug Class | HMG-CoA Reductase Inhibitor |
| Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for PRAVASTATIN SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for PRAVASTATIN SODIUM
Paragraph IV (Patent) Challenges for PRAVASTATIN SODIUM
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| PRAVACHOL | Tablets | pravastatin sodium | 30 mg | 019898 | 1 | 2005-06-01 |
US Patents and Regulatory Information for PRAVASTATIN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norvium Bioscience | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 079187-001 | May 27, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys Labs Inc | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 076714-004 | Dec 28, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pliva Hrvatska Doo | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 077730-002 | Nov 21, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 076939-004 | Oct 23, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
